Today: 11 June 2026
Browse Category

ASX:ORG 7 January 2026 - 27 April 2026

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin

Australia Stock Market Today: ASX 200 Falls For Fifth Day As Oil Shock Hits Banks, Origin

Australia’s S&P/ASX 200 fell 20.1 points, or 0.23%, to 8,766.40 on Monday, marking a fifth straight loss as energy, utilities, and banks declined. Origin Energy dropped 5.25% after weaker LNG revenue, while Atlas Arteria jumped on a takeover offer from IFM. Nine of 11 sectors fell. The Australian dollar traded near 71.61 U.S. cents late in the session.
27 April 2026
····
Octopus Energy’s Kraken lands $1bn funding round as spinout plans sharpen

Octopus Energy’s Kraken lands $1bn funding round as spinout plans sharpen

Ontario Teachers’ Pension Plan led a $1 billion funding round for Octopus Energy’s Kraken software unit, valuing it at $8.65 billion. Origin Energy will invest $140 million and keep a 22.7% stake. Octopus will retain 13.7% of Kraken after the planned separation, targeted for mid-2026 pending regulatory approval. Kraken serves over 70 million accounts and reported contracted annual revenue above $500 million.
7 January 2026
··

Stock Market Today

  • Fannie Mae (OTCPK:FNMA) Shares Dive 21% Amid Valuation Debate
    June 11, 2026, 10:38 AM EDT. Fannie Mae (FNMA) shares dropped about 21% in the past month, raising investor questions on valuation. Despite the pullback, FNMA boasts a 44% year-to-date decline but a strong 171% gain over five years. The perceived undervaluation, with a fair value estimate of $12.08 versus a last close near $6.17, hinges on optimistic long-term housing finance assumptions. FNMA's $4.1 trillion mortgage guaranty book and rising guaranty fees could support earnings growth. However, risks include weaker mortgage volumes and increasing credit stress in the multifamily segment. Investors are advised to weigh these factors carefully and consider other finance and housing stocks before investing.

Latest articles

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Redwire Stock Bounces as $500 Million Share Sale Draws Focus

Redwire Stock Bounces as $500 Million Share Sale Draws Focus

11 June 2026
Redwire stock jumped $1.24 to $16.11 Thursday after unveiling a $500 million at-the-market share sale, raising investor concerns about dilution versus growth funding; the new program could increase shares outstanding by about 11%, with the company’s 2026 revenue forecast and backlog now under scrutiny to justify the added supply.
Coupang Rises as $410 Million Korea Data Fine Finally Lands

Coupang Rises as $410 Million Korea Data Fine Finally Lands

11 June 2026
Coupang shares jumped 5.6% after South Korea imposed a record $410 million privacy fine for a 2025 data breach, as investors welcomed clarity on regulatory risk despite the penalty hitting Q2 operating expenses; the company plans to appeal, but ongoing customer trust and margin pressures remain key risks.
Go toTop